These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 31493506

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ.
    Breast Cancer Res; 2016 Sep 08; 18(1):90. PubMed ID: 27608715
    [Abstract] [Full Text] [Related]

  • 4. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
    Rodríguez-Martínez A, de Miguel-Pérez D, Ortega FG, García-Puche JL, Robles-Fernández I, Exposito J, Martorell-Marugan J, Carmona-Sáez P, Garrido-Navas MDC, Rolfo C, Ilyine H, Lorente JA, Legueren M, Serrano MJ.
    Breast Cancer Res; 2019 Feb 06; 21(1):21. PubMed ID: 30728048
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
    Joyce DP, Kerin MJ, Dwyer RM.
    Int J Cancer; 2016 Oct 01; 139(7):1443-8. PubMed ID: 27170104
    [Abstract] [Full Text] [Related]

  • 7. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
    Schwarzenbach H.
    Oncol Res Treat; 2017 Oct 01; 40(7-8):423-429. PubMed ID: 28683441
    [Abstract] [Full Text] [Related]

  • 8. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
    Motawi TM, Sadik NA, Shaker OG, El Masry MR, Mohareb F.
    Gene; 2016 Sep 30; 590(2):210-9. PubMed ID: 26827795
    [Abstract] [Full Text] [Related]

  • 9. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R.
    Gene; 2017 Jul 01; 619():10-20. PubMed ID: 28359916
    [Abstract] [Full Text] [Related]

  • 10. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
    Cecene G, Ak S, Eskiler GG, Demirdogen E, Erturk E, Gokgoz S, Polatkan V, Egeli U, Tunca B, Tezcan G, Topal U, Tolunay S, Tasdelen I.
    Asian Pac J Cancer Prev; 2016 Jul 01; 17(9):4241-4246. PubMed ID: 27797225
    [Abstract] [Full Text] [Related]

  • 11. Total Blood Exosomes in Breast Cancer: Potential Role in Crucial Steps of Tumorigenesis.
    Konoshenko M, Sagaradze G, Orlova E, Shtam T, Proskura K, Kamyshinsky R, Yunusova N, Alexandrova A, Efimenko A, Tamkovich S.
    Int J Mol Sci; 2020 Oct 05; 21(19):. PubMed ID: 33027894
    [Abstract] [Full Text] [Related]

  • 12. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P, Tanriverdi K, Curran C, Gilligan K, Freedman JE, Brown JAL, Kerin MJ.
    BMC Cancer; 2019 May 10; 19(1):436. PubMed ID: 31077182
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer.
    Gao S, Wang Y, Wang M, Li Z, Zhao Z, Wang RX, Wu R, Yuan Z, Cui R, Jiao K, Wang L, Ouyang L, Liu R.
    Oncotarget; 2017 Jun 20; 8(25):41451-41464. PubMed ID: 28562349
    [Abstract] [Full Text] [Related]

  • 15. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A, Intabli H, Alkhayal W, Eltabache C, Tweigieri T, Amer SB.
    BMC Cancer; 2017 Nov 28; 17(1):799. PubMed ID: 29183284
    [Abstract] [Full Text] [Related]

  • 16. Combination of miR-21 with Circulating Tumor Cells Markers Improve Diagnostic Specificity of Metastatic Breast Cancer.
    Yang X, Wang X, Shen H, Deng R, Xue K.
    Cell Biochem Biophys; 2015 Sep 28; 73(1):87-91. PubMed ID: 25669446
    [Abstract] [Full Text] [Related]

  • 17. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
    Madhavan B, Yue S, Galli U, Rana S, Gross W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW, Zöller M.
    Int J Cancer; 2015 Jun 01; 136(11):2616-27. PubMed ID: 25388097
    [Abstract] [Full Text] [Related]

  • 18. Translating microRNAs into biomarkers: What is new for pediatric cancer?
    de Carvalho IN, de Freitas RM, Vargas FR.
    Med Oncol; 2016 May 01; 33(5):49. PubMed ID: 27085875
    [Abstract] [Full Text] [Related]

  • 19. Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.
    Markou A, Zavridou M, Sourvinou I, Yousef G, Kounelis S, Malamos N, Georgoulias V, Lianidou E.
    Clin Chem; 2016 Jul 01; 62(7):1002-11. PubMed ID: 27197674
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic Value of Circulating miR-202 in Early-Stage Breast Cancer in South Korea.
    Kim J, Park S, Hwang D, Kim SI, Lee H.
    Medicina (Kaunas); 2020 Jul 09; 56(7):. PubMed ID: 32659906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.